Inventor · disambiguated record
Kevin Mcdonnell
Also filed as: MCDONNELL KEVIN · MCDONNELL KEVIN A · MCDONNELL KEVIN ANDREW
26 granted patents·23 pending applications·335 citations·filing 2007–2024
97Inventor score
Top patents by PatentIndex Score
49 records- 0197US11542304B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2020·Granted Jan 3, 2023·14 cites·20 claims
- 0297US11396530B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Jul 26, 2022·16 cites·22 claims
- 0397US11332500B2Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2020·Granted May 17, 2022·23 cites·21 claims
- 0496US12049520B2Bicyclic peptide ligands specific for CD137BICYCLETX LTD·Filed 2022·Granted Jul 30, 2024·14 cites·24 claims
- 0596US11970553B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2022·Granted Apr 30, 2024·14 cites·21 claims
- 0696US11312749B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2020·Granted Apr 26, 2022·24 cites·21 claims
- 0796US11306123B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2020·Granted Apr 19, 2022·24 cites·19 claims
- 0896US10919937B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2019·Granted Feb 16, 2021·29 cites·25 claims
- 0996US10875894B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2019·Granted Dec 29, 2020·26 cites·29 claims
- 1095US11453703B2Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2019·Granted Sep 27, 2022·15 cites·17 claims
- 1195US11261214B2Bicyclic peptide ligand specific for CD137BICYCLETX LTD·Filed 2018·Granted Mar 1, 2022·16 cites·25 claims
- 1295US9260520B2Antibodies to FeRn and uses thereofDYAX CORP·Filed 2014·Granted Feb 16, 2016·18 cites·6 claims
- 1394US8815246B2Fc receptor binding proteinsTENHOOR CHRISTOPHER·Filed 2012·Granted Aug 26, 2014·18 cites·12 claims
- 1494US8273351B2Fc receptor binding proteinsTENHOOR CHRISTOPHER·Filed 2009·Granted Sep 25, 2012·20 cites·6 claims
- 1593US11613560B2Bicyclic peptide ligands specific for OX40BICYCLETX LTD·Filed 2020·Granted Mar 28, 2023·15 cites·26 claims
- 1690US8101186B2Peptides that block the binding of IgG to FcRnMEZO ADAM R·Filed 2007·Granted Jan 24, 2012·24 cites·33 claims
- 1789US8906844B2Immunomodulatory peptidesMEZO ADAM R·Filed 2008·Granted Dec 9, 2014·7 cites·20 claims
- 1888US12150998B2Bicyclic peptide ligands specific for P-selectinBICYCLETX LTD·Filed 2022·Granted Nov 26, 2024·1 cites·23 claims
- 1986US12435107B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2024·Granted Oct 7, 2025·0 cites·21 claims
- 2084US10588935B2FC receptor (FcRn) binding peptides and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Mar 17, 2020·2 cites·14 claims
- 2183US10046023B2FC receptor (FcRn) binding peptides and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Aug 14, 2018·2 cites·11 claims
- 2282US9527890B2FC receptor (FcRn) binding peptides and uses thereofTHE BRIGHAM AND WOMENS'S HOSPITAL INC·Filed 2014·Granted Dec 27, 2016·5 cites·9 claims
- 2382US9012603B2Peptides that block the binding of IgG to FcRnMEZO ADAM R·Filed 2009·Granted Apr 21, 2015·6 cites·44 claims
- 2479US2025059236A1Bicyclic peptide ligands specific for cd137BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 2578US10137088B2Therapeutic nanoparticles having EGFR ligands and methods of making and using samePFIZER·Filed 2016·Granted Nov 27, 2018·2 cites·9 claims
- 2675US12378288B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Granted Aug 5, 2025·0 cites·29 claims
- 2773US2025064950A1Bicyclic peptide ligands specific for p-selectinBICYCLETX LTD·Filed 2024·Application pending·0 cites
- 2867US2023008076A1Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 2967US2019183964A1FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOFBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 3067US2022306694A1Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 3165US2016222110A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3265US2013045218A1Fc receptor binding proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3363US2016194397A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3463US2016222111A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3563US2016222112A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3663US2016222109A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3763US2016222108A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3857US2025186539A2Methods for treating cancerBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 3954US2012021484A1Recombinant FcRn and Variants Thereof for Purification of Fc-Containing Fusion ProteinsMCDONNELL KEVIN A·Filed 2009·Application pending·0 cites
- 4052US2019029960A1Therapeutic Nanoparticles Having EGFR Ligands and Methods of Making and Using SamePFIZER·Filed 2018·Application pending·0 cites
- 4152US2022194983A1Peptide ligands for binding to psmaBICYCLETX LTD·Filed 2019·Application pending·0 cites
- 4250US12492224B2Bicyclic peptide ligands specific for PD-L1BICYCLETX LTD·Filed 2019·Granted Dec 9, 2025·0 cites·27 claims
- 4350US2022275053A1Modified multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 4449US2020291096A1Bicyclic peptide ligand sting conjugates and uses thereofBICYCLERD LTD·Filed 2018·Application pending·0 cites
- 4549US2010048488A1Immunomodulatory peptidesSYNTONIX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4647US2024108738A1Bicyclic peptide ligands specific for nk cellsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 4747US2010310561A1Natriuretic fusion proteinsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 4846US2024197897A1Heterotandem bicyclic peptide complexesBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 4943US2020283482A1Bicyclic peptide ligand prr-a conjugates and uses thereofBICYCLERD LTD·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →